GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Navamedic ASA (FRA:N1A) » Definitions » EV-to-Revenue

Navamedic ASA (FRA:N1A) EV-to-Revenue : 1.42 (As of May. 17, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Navamedic ASA EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Navamedic ASA's enterprise value is €62.76 Mil. Navamedic ASA's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €44.15 Mil. Therefore, Navamedic ASA's EV-to-Revenue for today is 1.42.

The historical rank and industry rank for Navamedic ASA's EV-to-Revenue or its related term are showing as below:

FRA:N1A' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.26   Med: 0.84   Max: 2.36
Current: 1.43

During the past 13 years, the highest EV-to-Revenue of Navamedic ASA was 2.36. The lowest was 0.26. And the median was 0.84.

FRA:N1A's EV-to-Revenue is ranked worse than
68.04% of 97 companies
in the Medical Distribution industry
Industry Median: 0.6 vs FRA:N1A: 1.43

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-17), Navamedic ASA's stock price is €2.87. Navamedic ASA's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €2.50. Therefore, Navamedic ASA's PS Ratio for today is 1.15.


Navamedic ASA EV-to-Revenue Historical Data

The historical data trend for Navamedic ASA's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navamedic ASA EV-to-Revenue Chart

Navamedic ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.34 1.41 2.05 1.57 1.51

Navamedic ASA Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.05 - 1.57 - 1.51

Competitive Comparison of Navamedic ASA's EV-to-Revenue

For the Medical Distribution subindustry, Navamedic ASA's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Navamedic ASA's EV-to-Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Navamedic ASA's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Navamedic ASA's EV-to-Revenue falls into.



Navamedic ASA EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Navamedic ASA's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=62.755/44.153
=1.42

Navamedic ASA's current Enterprise Value is €62.76 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Navamedic ASA's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €44.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Navamedic ASA  (FRA:N1A) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Navamedic ASA's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=2.87/2.503
=1.15

Navamedic ASA's share price for today is €2.87.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was €2.50.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Navamedic ASA EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Navamedic ASA's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Navamedic ASA (FRA:N1A) Business Description

Traded in Other Exchanges
Address
Henrik Ibsensgate 100, Solli Plass, Lysaker, NOR, N-0255
Navamedic ASA is a pharmaceutical company that operates in a single segment, which is marketing, selling, and distributing pharmaceuticals and medical nutrition products to hospitals, pharmacies, and patients, bought from product suppliers and manufacturers in Europe and other places. Its product categories include Medical nutrition, Consumer health, Branded generics, and Specialty pharma.

Navamedic ASA (FRA:N1A) Headlines

No Headlines